Kymera Therapeutics, Inc. (KYMR)
NASDAQ: KYMR · Real-Time Price · USD
64.94
+1.31 (2.06%)
At close: Nov 14, 2025, 4:00 PM EST
65.10
+0.16 (0.25%)
After-hours: Nov 14, 2025, 6:16 PM EST
Kymera Therapeutics Market Cap
Kymera Therapeutics has a market cap or net worth of $4.67 billion as of November 14, 2025. Its market cap has increased by 53.74% in one year.
Market Cap
4.67B
Enterprise Value
3.78B
1-Year Change
53.74%
Ranking
Category
Stock Price
$64.94
Market Cap Chart
Since the IPO on August 21, 2020, Kymera Therapeutics's market cap has increased from $834.48M to $4.67B, an increase of 459.91%. That is a compound annual growth rate of 38.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 14, 2025 | 4.67B | 79.33% |
| Dec 31, 2024 | 2.61B | 84.43% |
| Dec 29, 2023 | 1.41B | 3.16% |
| Dec 30, 2022 | 1.37B | -57.98% |
| Dec 31, 2021 | 3.26B | 18.59% |
| Dec 31, 2020 | 2.75B | 229.33% |
| Aug 21, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 915.86B |
| Johnson & Johnson | 470.41B |
| AbbVie | 410.55B |
| UnitedHealth Group | 301.21B |
| AstraZeneca | 276.17B |
| Novartis AG | 256.16B |
| Merck & Co. | 230.65B |
| Abbott Laboratories | 224.77B |